Lost In The Middle: Why Value Added Products Need Better Pricing Mechanisms
This article was originally published in Scrip
Executive Summary
Europe needs better pricing systems for so-called value added medicines if the market for such products is to be sustainable or attractive, Warrick Smith, director general of the British Generic Manufacturers Association, the BGMA, told Scrip.